# Exhibit Review — Gemini 3 Flash (Round 1)

**Role:** Visual exhibit advisor
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-02-09T20:30:19.179312
**Route:** Direct Google API + PDF
**Tokens:** 27237 in / 2390 out
**Response SHA256:** eec9d2e3d5c5f2bb

---

This review evaluates the visual exhibits of the paper for submission to top-tier economics journals. The paper uses a sophisticated staggered DiD/DDD framework, and the exhibits generally reflect this high level of technical rigor.

# Exhibit-by-Exhibit Review

## Main Text Exhibits

### Table 1: "Event-Time Mapping by Adoption Cohort and ACS Survey Year"
**Page:** 10
- **Formatting:** Clean and professional. Good use of horizontal rules (booktabs style).
- **Clarity:** Excellent. It immediately explains how the staggered treatment interacts with the missing 2020 data.
- **Storytelling:** Essential for a staggered DiD paper. It establishes the "empty" cells and the definition of the post-PHE period.
- **Labeling:** Clear.
- **Recommendation:** **KEEP AS-IS**

### Table 2: "Summary Statistics: Postpartum Women (Pre-Treatment, 2017–2019)"
**Page:** 12
- **Formatting:** Standard journal format. Numbers are appropriately rounded.
- **Clarity:** High. Grouping by Treated vs. Control is standard.
- **Storytelling:** Supports the parallel trends assumption by showing baseline balance. 
- **Labeling:** Good. Note defines the sample and weighting.
- **Recommendation:** **REVISE**
  - **Change needed:** Add a third column for the "Difference" or "p-value" of a t-test between Treated and Control states. Top journals expect a formal test of balance, especially with a control group as small as N=4.

### Figure 1: "Raw Trends in Postpartum Insurance Coverage by Adoption Timing"
**Page:** 13
- **Formatting:** Professional. Use of gray shading for PHE is excellent.
- **Clarity:** The top panel (Medicaid) is clear. The bottom panel (Uninsurance) is slightly cluttered.
- **Storytelling:** This is the "money shot" for the paper's mechanism. It visually shows the "unwinding" steepening in early adopter states.
- **Labeling:** Legend is clear. 
- **Recommendation:** **REVISE**
  - **Change needed:** Increase the font size of the axis labels and the "PHE ends" annotation. Ensure the dotted line for the "PHE end" is consistently labeled across both panels.

### Table 3: "Effect of Postpartum Medicaid Extensions on Insurance Coverage"
**Page:** 18
- **Formatting:** Professional AER-style layout. Numbers are decimal-aligned.
- **Clarity:** Good, but the blank cells in Columns 4–5 for Panels B–D make the table look "holey."
- **Storytelling:** This is the central results table. Grouping by Estimation strategy (Panels A–D) is logical. 
- **Labeling:** Excellent notes. Defining the proportions (e.g., -0.0218 = -2.18 pp) is helpful for readers.
- **Recommendation:** **REVISE**
  - **Change needed:** Consolidation. Panel B (TWFE) is labeled as "biased benchmark." This can be moved to the appendix. In the main text, focus on CS-DiD and DDD. Fill the blank cells by running the low-income specs for the other panels if possible, or use "---" to denote they were intentionally omitted.

### Figure 2: "Event-Study Estimates: Callaway-Sant’Anna Dynamic Aggregation (Extended)"
**Page:** 20
- **Formatting:** High quality. Proper use of confidence bands.
- **Clarity:** Three panels are a lot for one figure. The y-axis scales differ, which is appropriate but requires the reader to look closely.
- **Storytelling:** Validates pre-trends for the main outcomes.
- **Labeling:** Clear.
- **Recommendation:** **KEEP AS-IS**

### Figure 3: "Triple-Difference (DDD) Estimates"
**Page:** 21
- **Formatting:** Consistent with Figure 2.
- **Clarity:** Very clean.
- **Storytelling:** This is the "preferred" result. It belongs in the main text.
- **Labeling:** Title is descriptive.
- **Recommendation:** **KEEP AS-IS**

### Figure 4: "Calendar-Time ATTs: PHE Period vs. Post-PHE Period"
**Page:** 23
- **Formatting:** Good use of side-by-side comparison.
- **Clarity:** The left panel is slightly "noisy" with the overlapping error bars.
- **Storytelling:** Crucial for the "Unwinding" story.
- **Labeling:** Good.
- **Recommendation:** **REVISE**
  - **Change needed:** In the right panel (bar chart), ensure the y-axis matches the left panel exactly to allow for easier visual comparison of the point estimates.

### Figure 5: "Cumulative Adoption of Medicaid Postpartum Coverage Extensions"
**Page:** 24
- **Formatting:** Clean.
- **Clarity:** High.
- **Storytelling:** Provides the "staggered" context.
- **Labeling:** Good.
- **Recommendation:** **MOVE TO APPENDIX** (This is a descriptive "background" figure; Table 1 and Figure 6 cover this information sufficiently for the main text).

### Figure 6: "Geographic Distribution of Adoption"
**Page:** 25
- **Formatting:** Standard map.
- **Clarity:** Good color choice (blue for treated, red for control).
- **Storytelling:** Shows the regional concentration (or lack thereof).
- **Labeling:** Legend is clear.
- **Recommendation:** **KEEP AS-IS**

### Figure 7: "Permutation Inference: Distribution of Placebo CS-DiD ATTs (200 Randomizations)"
**Page:** 26
- **Formatting:** Professional.
- **Clarity:** The "Actual" line vs. "Mirror" line is a great touch.
- **Storytelling:** Addresses the "few clusters" concern head-on.
- **Labeling:** Clear p-value and N.
- **Recommendation:** **KEEP AS-IS**

### Table 4: "Robustness Checks"
**Page:** 27
- **Formatting:** Summary table style.
- **Clarity:** Excellent. It's a "dashboard" of the paper's results.
- **Storytelling:** Highly effective. It shows the result is robust to everything *except* the unwinding period.
- **Labeling:** Clear.
- **Recommendation:** **KEEP AS-IS**

### Figure 8: "DDD Pre-Trend Event Study: Differenced Outcome..."
**Page:** 29
- **Formatting:** Consistent.
- **Clarity:** High.
- **Storytelling:** The most important diagnostic for the DDD.
- **Labeling:** Good.
- **Recommendation:** **KEEP AS-IS**

### Table 5: "DDD Pre-Treatment Event-Study Coefficients"
**Page:** 30
- **Formatting:** Simple.
- **Clarity:** Good.
- **Storytelling:** Quantifies the visual in Figure 8.
- **Labeling:** Includes joint F-test (essential).
- **Recommendation:** **MOVE TO APPENDIX** (The figure is enough for the main text).

### Figure 9: "HonestDiD Sensitivity: Robust Confidence Intervals Across M-Grid"
**Page:** 31
- **Formatting:** Standard HonestDiD output style.
- **Clarity:** Very high.
- **Storytelling:** Shows that the results aren't just a fluke of the parallel trends assumption.
- **Labeling:** Includes the "ATT = -0.005" reference.
- **Recommendation:** **KEEP AS-IS**

### Table 6: "Post-PHE Treatment Effect Heterogeneity"
**Page:** 34
- **Formatting:** Good panel structure.
- **Clarity:** High.
- **Storytelling:** Explores *why* the effect is small (e.g., race/expansion status).
- **Labeling:** Good.
- **Recommendation:** **KEEP AS-IS** (Though consider consolidating with Table 7).

### Table 7: "Cohort-Specific Average Treatment Effects"
**Page:** 35
- **Formatting:** Simple.
- **Clarity:** High.
- **Storytelling:** Essential to show that one specific cohort isn't driving the null.
- **Labeling:** Good.
- **Recommendation:** **REVISE**
  - **Change needed:** Merge this into Table 6 as "Panel D: By Adoption Cohort" to save space and group heterogeneity together.

---

## Appendix Exhibits

### Table 8: "Sample Sizes by Year"
**Page:** 47
- **Recommendation:** **KEEP AS-IS**

### Figure 10: "Event-Study Estimates: Low-Income Postpartum Women (Below 200% FPL)"
**Page:** 48
- **Recommendation:** **PROMOTE TO MAIN TEXT** (The low-income sample is theoretically where the policy should have the most "bite." Having this in the main text next to Figure 2 is standard for health policy papers).

### Table 9: "State Adoption of 12-Month Medicaid Postpartum Coverage"
**Page:** 50
- **Recommendation:** **KEEP AS-IS** (Excellent reference table).

---

## Overall Assessment

- **Exhibit count:** 7 main tables, 9 main figures, 2 appendix tables, 1 appendix figure.
- **General quality:** Extremely high. The paper follows modern "State of the Art" DiD practices (Callaway-Sant'Anna, HonestDiD, Permutation tests). The visuals match this sophistication.
- **Strongest exhibits:** Figure 1 (Visual identification), Figure 7 (Inference transparency), Table 4 (Robustness dashboard).
- **Weakest exhibits:** Table 2 (missing balance tests), Table 3 (unnecessary TWFE Panel B in main text).
- **Missing exhibits:** A table/figure showing the "Medicaid Unwinding" intensity by state. Since this is the primary confounder, a map or scatterplot showing the correlation between adoption timing and the scale of the 2023-2024 Medicaid enrollment drop would be very persuasive.

### Top 3 Improvements:
1.  **Add Balance Tests to Table 2:** Provide p-values for differences between treated and control states to satisfy reviewers on the "small control group" issue.
2.  **Consolidate Heterogeneity:** Merge Tables 6 and 7 into a single comprehensive heterogeneity table. 
3.  **Streamline Main Results:** Move Figure 5 (Cumulative adoption) to the appendix and move Figure 10 (Low-income event study) to the main text. The low-income subgroup is more central to the economic story than the cumulative adoption curve.